OpenMedQ: New Open-Source Medical Vision-Language Model Achieves State-of-the-Art Performance
Researchers have released OpenMedQ, a medical vision-language model pretrained on approximately 3.35 million samples across 14 fully open datasets covering pathology, radiology, microscopy, and clinical QA. The model achieves state-of-the-art BLEU-1 scores on PathVQA and matches top results on VQA-MED, outperforming Google's Med-PaLM M variants with up to 562 billion parameters. The work is significant because it demonstrates that a fully open, reproducible model can rival or surpass proprietary systems many times larger, lowering barriers for medical AI research.
OpenMedQ is a medical vision-language model introduced by researchers and accepted to the Medical Imaging with Deep Learning (MIDL) 2026 Short Paper Track. It was pretrained on the broadest fully open medical dataset mix reported to date, comprising roughly 3.35 million samples drawn from 14 datasets spanning pathology, radiology, microscopy, and text-only clinical question answering. On the PathVQA benchmark, OpenMedQ achieves a BLEU-1 score of 75.9, surpassing Med-PaLM M variants of up to 562 billion parameters — models approximately 80 times larger. It also matches the best reported BLEU-1 of 64.5 on the VQA-MED benchmark. When its vision encoder is transferred to eight unseen medical image classification benchmarks using a standardized downstream recipe, it achieves the highest average macro-F1 of 0.757, edging out established models such as BiomedCLIP, PMC-CLIP, and PubMedCLIP. The authors have released their code and an interactive demo to serve as a reproducible community baseline.
What's missing
The paper does not detail the parameter count or model size of OpenMedQ itself, making direct efficiency comparisons with the models it outperforms difficult to assess. The study's own scope is limited to specific benchmarks and does not address clinical deployment, safety evaluation, or performance on non-English medical data.
What different sources said
- arXiv cs.AICenter
OpenMedQ: Broad Open Pretraining for Medical Vision-Language Models
Related
Gut Bacteria Enzyme Found to Break Down Heat-Processed Food Compounds, Producing Novel Biogenic Amines
Researchers have discovered that an enzyme in common gut bacteria can degrade N-epsilon-carboxymethyllysine (CML), a compound formed during thermal food processing, producing previously unknown biogenic amines. The enzyme, ornithine decarboxylase SpeC from enterobacteria, acts on CML and related modified lysine derivatives through a low-level 'underground' catalytic activity. This finding suggests a previously unrecognized communication axis between thermally processed dietary compounds and gut microbial physiology, with potential implications for host health.
Full-Length Gene Sequencing Reveals Two Distinct Bacterial Communities in Black-Legged Ticks Expanding Into Canada
Researchers used Oxford Nanopore full-length 16S rRNA gene sequencing to characterize the microbiome of Ixodes scapularis black-legged ticks collected in Nova Scotia, Canada, distinguishing between tick-adapted bacteria and environmentally acquired bacteria. The study comes as I. scapularis — the primary vector of Lyme disease — is rapidly expanding northward into Canada due to climate change. The findings suggest that environmentally derived bacteria in tick microbiomes are not mere contamination, which has implications for how tick microbiome data is collected and interpreted across surveillance studies.
Study Identifies Metabolic Link Between Cell Envelope Stress and Biofilm Formation in Bacteria
Researchers have discovered that the metabolite acetyl-CoA directly inhibits enzymes that degrade the bacterial signaling molecule c-di-GMP, connecting cell envelope biosynthesis stress to biofilm formation in Pseudomonas aeruginosa. The study found that sub-inhibitory concentrations of antibiotics targeting early peptidoglycan biosynthesis — but not other antibiotic classes — elevate c-di-GMP levels by reducing phosphodiesterase activity, with acetyl-CoA competing for the enzyme active site. Because the relevant enzyme domain is broadly conserved across bacterial species, this checkpoint mechanism may be widespread and could have implications for understanding antibiotic-induced biofilm responses.